Video

Gut vs. Science: When a Patient Presents with Chest Pain

Robert Roswell, MD, of NYU School of Medicine, discussed how much a physician's gut really comes into play when diagnosing chest pain at the American College of Physicians Internal Medicine Meeting (ACP 2017) in San Diego, California.

Chest pain can be cardiac in nature, but then again, it might not be. Deciphering between the two is incredibly important, and sometimes patients head to their primary care physician instead of going to the emergency department or calling 911. When that happens, how much does a doctor’s gut come into play before making the next step decision?

Robert Roswell, MD, assistant professor of medicine at the New York University (NYU) School of Medicine and director of the Cardiac Care Unit and Outpatient Cardiology at Bellevue Hospital, talked to MD Magazine about that very thing at the American College of Physicians Internal Medicine Meeting (ACP 2017) in San Diego, California.

“I think as physicians our gut goes into play a lot,” Roswell said, “and I think most of the time it’s a very good thing.”

However, Roswell recognized that sometimes a hunch can work against physicians. Myocardial infarction or cardiovascular disease, for example, might not present the same way in patient populations.

“I think it’s really important for all of us to acknowledge that we have instincts and hunches, but be sure that doesn’t really affect how we’re treating patients,” Roswell concluded.

>>> More Coverage from ACP 2017

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.